Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort

Keyphrases

• Clinical Outcomes 100%
• Urinary Tract Infection 100%
• Treatment Outcome 100%
• Retrospective Cohort 100%
• Klebsiella Pneumoniae Carbapenemase 100%
• Carbapenemase-producing Enterobacteriaceae 100%
• Antibiotics 25%
• Aminoglycosides 25%
• Retrospective Cohort Study 12%
• Well-defined 12%
• Exclusion Criteria 12%
• Appropriate Therapy 12%
• Molecular Methods 12%
• Adult Inpatients 12%
• High Susceptibility 12%
• Tigecycline 12%
• Susceptibility Testing 12%
• Urinary Catheter 12%
• In Vitro Testing 12%
• Minocycline 12%
• Therapeutic Promises 12%
• Susceptibility Rate 12%
• Disc Diffusion 12%
• Symptomatic Urinary Tract Infection 12%
• Bacteriuria 12%
• Fosfomycin 12%
• Tetracycline Derivatives 12%
• Jews 12%
• Optimal Treatment Regimen 12%

Immunology and Microbiology

• Infectious Disease 100%
• Urinary Tract 100%
• Klebsiella pneumoniae 100%
• Carbapenemase Producing Enterobacteriaceae 100%
• Infection 100%
• Susceptibility 25%
• Infectious Agent 12%
• Disk Diffusion 12%
• Antimicrobial Agent 12%
• In Vitro 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Urinary Tract Infection 100%
• Carbapenemase Producing Enterobacteriaceae 100%
• Klebsiella pneumoniae 100%
• Carbapenemase 50%
• Aminoglycoside 25%
• Infection 12%
• Cohort Study 12%
• Antibiotics 12%
• Infectious Agent 12%
• Tigecycline 12%
• Tetracycline 12%
• Bacteriuria 12%
• Minocycline 12%
• Fosfomycin 12%
• Antimicrobial Agent 12%